Skip to main content
SpringerLink
Log in

Retracted: Human Papillomaviruses and Squamous Cell Carcinomas of Head and Neck Region

  • Chapter
  • First Online:
Contemporary Oral Oncology

  • 1045 Accesses

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy reported worldwide, with an estimated global burden of approximately 550,000 incident cases and 300,000 deaths per year and a high case fatality rate. Squamous cell carcinoma of the head and neck (HNSCC) is an anatomically heterogeneous group of neoplasms arising from the mucosal surface of the lips, oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, tonsils, and larynx. Each year approximately 263,000 cases of oral cavity cancer and 135,000 cases of pharyngeal cancer are diagnosed worldwide [20]. Oral squamous cell carcinoma (OSCC) and oropharyngeal squamous cell carcinoma (OPSCC) are the most common types of HNSCC. Approximately 50 % of HNSCCs are in the oral cavity, followed by 30 % in the larynx and 10 % in the oropharynx. Alcohol consumption, smoking, smokeless tobacco, poor oral hygiene, and genetic features are key risk factors for HNSCC development [50]. In addition, in the last decade it has become clear that a subset of HNSCC covering approximately 25 % of the worldwide cases is associated with certain HPV types.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Change history

  • 28 May 2020

    Chapter [7] has been retracted by the publisher. The chapter contains sections that substantially overlap with the following articles [2,3]. All authors agree to the retraction.

References

  1. Albarran Y Carvajal A, de la Garza A, Cruz Quiroz BJ, Vazquez Zea E, Díaz Estrada I, Mendez Fuentez E, López Contreras M, Andrade-Manzano A, Padilla S, Varela AR, Rosales R. MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study. BioDrugs. 2007;21(1):47–59.

    CAS  PubMed  Google Scholar 

  2. Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, Deleo A, Fer- ris RL. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res. 2005;65:11146–55.

    CAS  PubMed  Google Scholar 

  3. Antonsson A, Cornford M, Perry S, Davis M, Dunne MP, Whiteman DC. Prevalence and risk factors for oral HPV infection in young Australians. PLoS One. 2014;9(3).

    Google Scholar 

  4. Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, Lindholm J, Marklund L, Dalianis T, Munck-Wikland E. The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer. 2010;126:2879–84.

    CAS  PubMed  Google Scholar 

  5. Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A, Besnier N, Gey A, Rotem-Yehudar R, Pere H, Tran T, Guerin CL, Chauvat A, Dransart E, Alanio C, Albert S, Barry B, Sandoval F, Quintin-Colonna F, Bruneval P, Fridman WH, Lemoine FM, Oudard S, Johannes L, Olive D, Brasnu D, Tartour E. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. Cancer Res. 2013;73:128–38.

    CAS  PubMed  Google Scholar 

  6. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, Chan SY. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections. Int J Cancer. 1995;61:450–4.

    CAS  PubMed  Google Scholar 

  7. Bassioukas K, Danielides V, Georgiou I. Oral focal epithelial hyperplasia. Eur J Dermatol. 2000;10(5):395–7.

    CAS  PubMed  Google Scholar 

  8. Blomberg M, Nielsen A, Munk C, Krüger Kjaer S. Trends in head and neck cancer incidence in Denmark, 1978–2007: focus on human papillomavirus associated sites. Int J Cancer. 2011;129:733–41.

    CAS  PubMed  Google Scholar 

  9. Braakhuis BJ, Snijders PJ, Keune WJ, Meijer CJ, Ruijter-Schippers HJ, Leemans CR, Brakenhoff RH. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst. 2004;96:998–1006.

    CAS  PubMed  Google Scholar 

  10. Castro TMPPG, Filho IB. Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx. Braz J Otorhinolaryngol. 2006;72(2):272–82.

    PubMed  Google Scholar 

  11. Castro TMPPG, Neto CER, Scala KA. Oral manifestations related to papilloma‐virus. Braz J Otorhinolaryngol. 2004;70(4):546–50.

    Google Scholar 

  12. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–9.

    PubMed  Google Scholar 

  13. Corona Gutierrez CM, Tinoco A, Navarro T, Contreras MLP, Cortes RR, Calzado P, Reyes L, Posternak R, Morosoli G, Verde ML, Rosales R. Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus. Hum Gene Ther. 2004;15(5):421–31.

    CAS  PubMed  Google Scholar 

  14. D’Costa J, Saranath D, Dedhia P, Sanghvi V, Mehta AR. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol. 1998;34:413–20.

    PubMed  Google Scholar 

  15. D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263–9.

    PubMed  PubMed Central  Google Scholar 

  16. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case–control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944–56.

    PubMed  Google Scholar 

  17. Delgado Y, Torrelo A, Colmenero I. Hiplerplasia epitelial focal. Actas Dermosifiliogr. 2005;96(10):697–9.

    PubMed  Google Scholar 

  18. Doorbar J, Quint W, Banks L, Bravod IG, Stolere M, Brokerf TR, Stanleyg MA. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30 Suppl 5(20):F55–70.

    PubMed  Google Scholar 

  19. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261–9.

    CAS  PubMed  Google Scholar 

  20. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.

    CAS  PubMed  Google Scholar 

  21. Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem. 2002;277:21730–9.

    CAS  PubMed  Google Scholar 

  22. Finnen RL, Erickson KD, Chen XS, Garcea RL. Interactions between papillomavirus L1 and L2 capsid proteins. J Virol. 2003;77(8):4818–26.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Frazer IH, Lowy DR, Schiller JT. Prevention of cancer through immunization: prospects and challenges for the 21st century. Eur J Immunol. 2007;37:S148–55.

    CAS  PubMed  Google Scholar 

  24. Gajalakshmi V, Hung RJ, Mathew A, Varghese C, Brennan P, Boffetta P. Tobacco smoking and chewing, alcohol drinking and lung cancer risk among men in southern India. Int J Cancer. 2003;107:441–7.

    CAS  PubMed  Google Scholar 

  25. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928–43.

    CAS  PubMed  Google Scholar 

  26. Garnett T, Duerksen-Hughes P. Modulation of apoptosis by human papillomavirus (HPV) oncoproteins. Arch Virol. 2006;151:2321–35.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Gheit T, Vaccarella S, Schmitt M, Pawlita M, Franceschi S, Sankaranarayanan R, Sylla BS, Tommasino M, Gangane N. Prevalence of human papillomavirus types in cervical and oral cancers in central India. Vaccine. 2009;27:636–9.

    CAS  PubMed  Google Scholar 

  28. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B, Tommasino M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes. 2010;40:1–13.

    CAS  PubMed  Google Scholar 

  29. Gissmann L, Boshart M, Dürst M, Ikenberg H, Wagner D, zur Hausen H. Presence of human papillomavirus in genital tumors. J Invest Dermatol. 1984;83:26S–8.

    CAS  PubMed  Google Scholar 

  30. Gubanova E, Brown BT, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N. Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Clin Cancer Res. 2012;18:1257–67.

    Google Scholar 

  31. Hemminki K, Dong C, Frisch M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev. 2000;9:433–7.

    CAS  PubMed  Google Scholar 

  32. Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One. 2013;8(7), e68329.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Heusinkveld M, Goedemans R, Briet RJ, Gelderblom H, Nortier JW, Gorter A, Smit VT, Langeveld AP, Jansen JC, van der Burg SH. Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer. Int J Cancer. 2012;131(2):E74–85.

    CAS  PubMed  Google Scholar 

  34. Hong AM, Grulich AE, Jones DD, Lee CS, Garland SM, Dobbins TA, Clark JR, Harnett GB, Milross CG, O’Brien CJ, Rose BR. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine. 2010;28:3269–72.

    CAS  PubMed  Google Scholar 

  35. IARC. Human papillomaviruses, vol. 64. Lyon: WHO; 1995.

    Google Scholar 

  36. IARC. Human papillomaviruses, vol. 90. Lyon: WHO; 2007.

    Google Scholar 

  37. James MA, Lee JH, Klingelhutz AJ. Human papillomavirus type 16 E6 activates NF-kappaB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J.Virol. 2006;80: 5301–7.

    Google Scholar 

  38. Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, Gill S, Frustino J, Wilding G, Loree T, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985–2010. Oral Oncol. 2011;47:1048–54.

    PubMed  PubMed Central  Google Scholar 

  39. Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, et al. Validation of methods for oropharyngeal cancer hpv status determination in us cooperative group trials. Am J Surg Pathol. 2012;36:945–54.

    PubMed  PubMed Central  Google Scholar 

  40. Jung AC, Briolat J, Millon R, de Reynies A, Rickman D, Thomas E, Abecassis J, Clavel C, Wasylyk B. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer. 2010;126:1882–94.

    CAS  PubMed  Google Scholar 

  41. Kim JJ, Goldie SJ. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359:821–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Kim L, King T, Agulnik M. Head and neck cancer: changing epidemiology and public health implications. Oncology. 2010;24: 915–9.

    PubMed  Google Scholar 

  43. King EM, Gilson R, Beddows S, Soldan K, Panwar K, Young C, Jit M, Edmunds WJ, Sonnenberg P. Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance. Sex Transm Infect. 2015;91(4):284–6. doi:10.1136/sextrans-2014-051955.

  44. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14:467–75.

    CAS  PubMed  Google Scholar 

  45. Kreimer AR, Johansson M, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013;31(21):2708–15.

    PubMed  PubMed Central  Google Scholar 

  46. Kumaraswamy KL, Vidhya M. Human papilloma virus and oral infections: an update. J Cancer Res Ther. 2011;7(2):120–7.

    CAS  PubMed  Google Scholar 

  47. Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, Clark JR, Wein RO, Grillone GA, Houseman EA, Halec G, Waterboer T, Pawlita M, Krane JF, Kelsey KT. Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res. 2012;72(19):5004–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Madinier I, Doglio A, Cagnon L, Lefebvre JC, Monteil RA. Southern blot detection of human papillomaviruses (HPVs) DNA sequences in gingival tissues. J Periodontol. 1992;63:667–73.

    CAS  PubMed  Google Scholar 

  49. Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L, Sowka M, Golusinski P, Malicki J, Golusinski W. Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol. 2014;48:1–10.

    PubMed  PubMed Central  Google Scholar 

  50. Martorell Calatayud A, Botella-Estrada R, Bagán-Sebastián JV. Oral leukoplakia: clinical, histopathologic, and molecular features and therapeutic approach. Actas Dermosifiliogr. 2009;100:669–84.

    CAS  PubMed  Google Scholar 

  51. Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11:781–9.

    PubMed  PubMed Central  Google Scholar 

  52. Mattoscio D, Casadio C, Fumagalli M, Sideri M, Chiocca S. The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. Ecancermedicalscience. 2015;9:534.

    PubMed  PubMed Central  Google Scholar 

  53. Miller DL, Michael D, Puricelli M, Stack S. Virology and molecular pathogenesis of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. Biochem J. 2012;443(2):339–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Mooij SH, Boot HJ, Speksnijder AGCL, Stolte IG, Meijer CJLM, Snijders PJF, Verhagen DWM, King AJ, de Vries HJC, Quint WGV, van der Sande MAB, van der Loeff MFS. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. AIDS. 2013;27:2117–28.

    PubMed  Google Scholar 

  55. Morshed K, Polz-Gruszka D, Szymański M, Polz-Dacewicz M. Human papillomavirus (HPV) – structure, epidemiology and pathogenesis. Otolaryngol Pol. 2014;68:213–9.

    PubMed  Google Scholar 

  56. Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer. 2002;97:649–53.

    CAS  PubMed  Google Scholar 

  57. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparen P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma. Int J Cancer. 2009;125:362–6.

    PubMed  Google Scholar 

  58. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G, Greenacre M. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374:301–14.

    CAS  PubMed  Google Scholar 

  59. Pannone G, Santoro A, Papagerakis S, Lo Muzio L, De Rosa G, Bufo P. The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview. Infect Agents Cancer. 2011;6:4.

    Google Scholar 

  60. Pillai MR, Nair MK. Development of a condemned mucosa syndrome and pathogenesis of human papilloma virus-associated upper aero-digestive tract and uterine cervical tumors. Exp Mol Pathol. 2000;69:233–41.

    CAS  PubMed  Google Scholar 

  61. Preuss SF, Weinell A, Molitor M, Stenner M, Semrau R, Drebber U, Weissenborn SJ, Speel EJ, Wittekindt C, Guntinas-Lichius O, Hoffmann TK, Eslick GD, Klussmann JP. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. Br J Cancer. 2008;98:627–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  62. Ragin C, Edwards R, Larkins-Pettigrew M, Taioli E, Eckstein S, Thurman N, Bloome J, Markovic N. Oral HPV infection and sexuality: a cross-sectional study in women. Int J Mol Sci. 2011;2011(12):3928–40.

    Google Scholar 

  63. Read TRH, Hocking JS, Vodstrcil LA, Tabrizi SN, McCullough MJ, Grulich AE, Garland SM, Bradshaw CS, Chen MY, Fairley CK. Oral human papillomavirus in men having sex with men: risk-factors and sampling. PLoS One. 2012;7:11.

    Google Scholar 

  64. Rosales C, Valadez-Graham V, Arrellin G, Merchant H, Rosales R. MVA E2 a recombinant vaccinia containing the papilloma virus E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity. Cancer Immunol Immunother. 2000;49(7):347–60.

    CAS  PubMed  Google Scholar 

  65. Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, Wu X, Chaturvedi AK, Kawaoka K. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer. 2008;113:2901–9.

    PubMed  Google Scholar 

  66. Santoro A, Pannone G, Contaldo M. A troubling diagnosis of verrucous squamous cell carcinoma (“the bad kind” of keratosis) and the need of clinical and pathological correlations: a review of the literature with a case report. J Skin Cancer. 2011;2011:370605.

    CAS  PubMed  Google Scholar 

  67. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129–36.

    CAS  PubMed  Google Scholar 

  68. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M, Meijer CJ, Braakhuis BJ, Leemans CR, Brakenhoff RH. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465–72.

    CAS  PubMed  Google Scholar 

  69. Smith EM, Ritchie JM, Summersgill KF, Hoffman HT, Wang DH, Haugen TH, Turek LP. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96(6).

    Google Scholar 

  70. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol. 1999;9:379–86.

    CAS  PubMed  Google Scholar 

  71. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol. 2004;57:449–55.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg. 1983;12(6):418–24.

    PubMed  Google Scholar 

  73. Tezal M. Interaction between chronic inflammation and oral HPV infection in the etiology of head and neck cancers. Int J Otolaryngol. 2012;2012:575242.

    PubMed  PubMed Central  Google Scholar 

  74. van Kempen PM, Noorlag R, Braunius WW, Stegeman I, Willems SM, Grolman W. Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma-A systematic review. Epigenetics. 2014;9(2):194–203.

    PubMed  Google Scholar 

  75. van Rijn VM, Mooij SH, Mollers M, Snijders PJ, Speksnijder AG, King AJ, de Vries HJ, van Eeden A, van der Klis FR, de Melker HE, van der Sande MA, van der Loeff MF. Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men. PLoS One. 2014;9:3.

    Google Scholar 

  76. Wansom D, Light E, Worden F, Prince M, Urba S, Chepeha DB, Cordell K, Eisbruch A, Taylor J, D’Silva N, Moyer J, Bradford CR, Kurnit D, Kumar B, Carey TE, Wolf GT. Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 2010;136(12):1267–73.

    PubMed  PubMed Central  Google Scholar 

  77. Ward MJ, Thirdborough SM, Mellows T, Riley C, Harris S, Suchak K, Webb A, Hampton C, Patel NN, Randall CJ, Cox HJ, Jogai S, Primrose J, Piper K, Ottensmeier CH, King EV, Thomas GJ. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br J Cancer. 2014;110:489–500.

    CAS  PubMed  Google Scholar 

  78. Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol. 2014;50(9):771–9.

    PubMed  PubMed Central  Google Scholar 

  79. zur Hausen H. Human papillomavirus and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol. 1977;78:1–30.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Kerala, Thiruvananthapuram, 695014, India

    Priya R. Prabhu & M. Radhakrishna Pillai

Authors
  1. Priya R. Prabhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Radhakrishna Pillai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Radhakrishna Pillai .

Editor information

Editors and Affiliations

  1. Department of Head and Neck, Plastic and Reconstructive Surgery, Roswell Park Cancer Institute, Buffalo, USA

    Moni Abraham Kuriakose

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Prabhu, P.R., Pillai, M.R. (2017). Retracted: Human Papillomaviruses and Squamous Cell Carcinomas of Head and Neck Region. In: Kuriakose, M.A. (eds) Contemporary Oral Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-14911-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14911-0_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14910-3

  • Online ISBN: 978-3-319-14911-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation